XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
2022 Notes
2025 Notes
Common shares
Preferred Stock
Common Stock
Common Stock
2025 Notes
Common Stock
Common shares
Additional Paid-in Capital
Additional Paid-in Capital
2022 Notes
Additional Paid-in Capital
2025 Notes
Additional Paid-in Capital
Common shares
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2020 $ (27,899)       $ 0 $ 99     $ 711,487       $ (732,422) $ (6,972) $ (91)
Beginning balance (shares) at Dec. 31, 2020         35 99,399                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) (16,959)                       (17,173)   214
Foreign currency translation adjustment (1,732)                         (1,732)  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 1,561         $ 1     1,560            
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)           1,429                  
Taxes withheld on net settled vesting of restricted stock units (468)               (468)            
Issuance of common shares in connection with conversion of notes     $ 5,383       $ 1       $ 5,382        
Issuance of common shares in connection with conversion of notes (shares)             429                
Issuance of shares       $ 29,428       $ 2       $ 29,426      
Issuance of shares (shares)               1,516              
Share-based compensation 9,098               9,098            
Net noncontrolling interest acquired 125                       241   (116)
Series E preferred stock dividends 0               867       (867)    
Ending balance at Mar. 31, 2021 (1,463)       $ 0 $ 103     757,352       (750,221) (8,704) 7
Ending balance (shares) at Mar. 31, 2021         35 102,773                  
Beginning balance at Dec. 31, 2021 (24,854)       $ 0 $ 105     770,619       (787,047) (8,531) 0
Beginning balance (shares) at Dec. 31, 2021         25 105,381                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) (25,223)                       (25,223)   0
Foreign currency translation adjustment 2,898                         2,898  
Adjustment relating to extinguishment of 2022 Notes   $ 1,728               $ 1,728          
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan 76         $ 2     74            
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (shares)           2,008                  
Taxes withheld on net settled vesting of restricted stock units (14)               (14)            
Share-based compensation 11,199               11,199            
Series E preferred stock dividends 0               661       (661)    
Ending balance at Mar. 31, 2022 $ (34,190)       $ 0 $ 107     $ 784,267       $ (812,931) $ (5,633) $ 0
Ending balance (shares) at Mar. 31, 2022         25 107,389